Diagnosis and treatment of sarcoma of the uterus. A review

CG Tropé, VM Abeler, GB Kristensen - Acta oncologica, 2012 - Taylor & Francis
Background. The histopathological classification and staging system for uterine sarcoma
(US) were revised in 2003 and 2009, respectively. However, there is currently no consensus …

[HTML][HTML] Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

I Vergote, CG Tropé, F Amant… - … England Journal of …, 2010 - Mass Medical Soc
Background Primary debulking surgery before initiation of chemotherapy has been the
standard of care for patients with advanced ovarian cancer. Methods We randomly assigned …

The invasive front of carcinomas. The most important area for tumour prognosis?

M Bryne, M Boysen, CG Alfsen, VM Abeler… - Anticancer …, 1998 - europepmc.org
Various molecular events of importance in tumour spread, like the gain and loss of adhesion
molecules, secretion of proteolytic enzymes, increased cell proliferation, and the initiation of …

[HTML][HTML] Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer (EC) is the most common gynaecologic malignancy in
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …

[HTML][HTML] Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

JT Chi, Z Wang, DSA Nuyten, EH Rodriguez… - PLoS …, 2006 - journals.plos.org
Background Inadequate oxygen (hypoxia) triggers a multifaceted cellular response that has
important roles in normal physiology and in many human diseases. A transcription factor …

Gene expression patterns in ovarian carcinomas

ME Schaner, DT Ross, G Ciaravino… - Molecular biology of …, 2003 - Am Soc Cell Biol
We used DNA microarrays to characterize the global gene expression patterns in surface
epithelial cancers of the ovary. We identified groups of genes that distinguished the clear …

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

VM Abeler, O Røyne, S Thoresen… - …, 2009 - Wiley Online Library
Aims: To determine the frequency and survival of the various types of uterine sarcoma in the
total population of Norway and evaluate histopathological prognostic factors in order to …

[HTML][HTML] Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 …

I Vergote, C Coens, M Nankivell, GB Kristensen… - The Lancet …, 2018 - thelancet.com
Background Individual patient data from two randomised trials comparing neoadjuvant
chemotherapy with upfront debulking surgery in advanced tubo-ovarian cancer were …

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]

I Vergote, GJS Rustin, EA Eisenhauer… - Journal of the …, 2000 - academic.oup.com
We read with much interest the article by Therasse et al.(1) on the new Response Evaluation
Criteria in Solid Tumors Group (RECIST) in the Journal. In the RECIST, the definition of …

[HTML][HTML] Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers

Å Helland, MS Anglesio, J George, PA Cowin… - PloS one, 2011 - journals.plos.org
Molecular subtypes of serous ovarian cancer have been recently described. Using data from
independent datasets including over 900 primary tumour samples, we show that …